Traduction de «delivery of » (Néerlandais → Français) :

Tabel 1. Survival, pregnancy and delivery rates after single embryo transfer of human blastocysts vitrified with either the Cryotop or the CryoTip method. Cryotop (open) Cryotip (gesloten) Survived/vitrified rate (%) 221/227 (97) 82/88 (93) Pregnancy/transfer rate (%) 131/221 (59) 42/82 (51) Delivery/transfer rate (%) 113/221 (51) 39/82 (48) No significant differences between corresponding values were found.
Tableau 1. Survival, pregnancy and delivery rates after single embryo transfer of human blastocysts vitrified with either the Cryotop or the CryoTip method Cryotop TM (ouvert) Cryotip TM (fermé) Survived/vitrified rate (%) 221/227 (97) 82/88 (93) Pregnancy/transfer rate (%) 131/221 (59) 42/82 (51) Delivery/transfer rate (%) 113/221 (51) 39/82 (48)

Managed Health Care Delivery Systems - Advies - Orde van geneesheren - Ordomedic
Managed Health Care Delivery Systems - Conseil - Ordre des médecins - Ordomedic

3 Article du Journal de l’Association médicale canadienne (JAMC), “ Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term”, [http ...]
3 Article du Journal de l’Association médicale canadienne (JAMC), “Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term”, [http ...]

In antwoord op uw vragen vervat in uw brief van 16 juli 1998 (ref. 3/1/4/26/2) kan de Nationale Raad van de Belgische Orde der Geneesheren u meedelen dat de Belgische zorgverstrekking tot op heden niet rechtstreeks wordt geconfronteerd met enige gestructureerde vorm van " managed health care delivery system" , zodat de Orde der Geneesheren tot op heden nog geen precieze houding noch richtlijn hiertegenover heeft aangenomen.
En réponse aux questions exposées dans votre lettre du 16 juillet 1998 (réf. : /1/4/26/2), le Conseil national de l'Ordre des médecins vous fait savoir que les soins de santé en Belgique n'ont pas encore été directement confrontés à une quelconque forme structurée de " managed health care delivery systems" . De ce fait, l'Ordre des médecins n'a à ce jour pas encore adopté de position ou de directive précise en la matière.

Simhan HN, Caritis SN: Prevention of Preterm Delivery N Engl J Med 2007; 357: 477-87
Simhan HN, Caritis SN: Prevention of Preterm Delivery N Engl J Med 2007; 357: 47 7-87

Farrell M. A review of the legislation, regulation and delivery of Methadon in 12 Member
Farrell M. A review of the legislation, regulation and delivery of Methadone in 12 Member States

Deliveries of H1N1 pandemic flu vaccines are underway as Novartis works at full capacity to meet public health demands.
Les livraisons du vaccin contre la pandémie de grippe H1N1 sont en cours, tandis que Novartis produit à pleine capacité pour répondre aux demandes issues de la santé publique.

Malaria kills a child under age five every 30 seconds in Africa Only 10% of R&D funds are used for research into 90% of the world’s health problems The NITD was granted USD 20 million in 2006 by the Wellcome Trust, the Singapore Economic Development Board and Medicines for Malaria Venture to initiate joint research on malaria Leprosy has dropped by over 90% since 1985 Deliveries for Coartem have climbed from four million treatments in 2004 to over 60 million in 2006
En Afrique, la malaria tue un enfant de moins de cinq ans toutes les 30 secondes Seuls 10% des fonds consacrés à la recherche sont investis dans les maladies qui représentent 90% des problèmes de santé dans le monde En 2006, l’Institut Novartis pour les maladies tropicales a obtenu du Wellcome Trust, du Singapore Economic Development Board et de Medicines for Malaria Venture USD 20 millions pour initier un programme commun de recherche sur la malaria Depuis 1985, la lèpre a diminué de plus de 90% Entre 2004 et 2006, les livraisons de Coartem sont passées de 4 millions à plus de 60 millions de traitements

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

“This effort builds on the ongoing work of many partners committed to improving the lives of the 1 billion people affected by NTDs, most of whom are among the world’s poorest. “At Pfizer, we are working to combat NTDs by collaborating on drug development, broadening access to medicines and strengthening health care delivery for underserved people.
“At Pfizer, we are working to combat NTDs by collaborating on drug development, broadening access to medicines and strengthening health care delivery for underserved people.